Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Condition: Relapsing Multiple Sclerosis Interventions: Drug: SAR442168; Drug: Teriflunomide HMR1726; Drug: Placebo to match SAR442168; Drug: Placebo to match Teriflunomide Sponsor: Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials